These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 36287201)
1. Cai Z; Liu R; Chan C; Lu Y; Winnik MA; Cescon DW; Reilly RM Mol Pharm; 2022 Nov; 19(11):4199-4211. PubMed ID: 36287201 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, Georgiou CJ; Cai Z; Alsaden N; Cho H; Behboudi M; Winnik MA; Rutka JT; Reilly RM Mol Pharm; 2023 Jan; 20(1):582-592. PubMed ID: 36516432 [TBL] [Abstract][Full Text] [Related]
3. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer. Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM J Nucl Med; 2016 Jun; 57(6):936-42. PubMed ID: 26848176 [TBL] [Abstract][Full Text] [Related]
4. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape. Reilly RM; Georgiou CJ; Brown MK; Cai Z EJNMMI Radiopharm Chem; 2024 May; 9(1):37. PubMed ID: 38703297 [TBL] [Abstract][Full Text] [Related]
5. Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with Lai P; Cai Z; Pignol JP; Lechtman E; Mashouf S; Lu Y; Winnik MA; Jaffray DA; Reilly RM Phys Med Biol; 2017 Oct; 62(22):8581-8599. PubMed ID: 29077574 [TBL] [Abstract][Full Text] [Related]
6. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model. Song HN; Jin H; Kim JH; Ha IB; Kang KM; Choi HS; Jeong HJ; Kim MY; Kim HJ; Jeong BK Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638817 [TBL] [Abstract][Full Text] [Related]
7. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer. Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954 [TBL] [Abstract][Full Text] [Related]
8. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response. Zhang X; Niedermann G Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901 [TBL] [Abstract][Full Text] [Related]
9. Preclinical Study of a Fully Human Anti-PD-L1 Antibody as a Theranostic Agent for Cancer Immunotherapy. Xu M; Han Y; Liu G; Xu Y; Duan D; Liu H; Du F; Luo P; Liu Z Mol Pharm; 2018 Oct; 15(10):4426-4433. PubMed ID: 30133286 [TBL] [Abstract][Full Text] [Related]
10. Transient Vasodilation in Mouse 4T1 Tumors after Intragastric and Intravenous Administration of Gold Nanoparticles. Brzoska K; Szczygiel M; Drzał A; Sniegocka M; Michalczyk-Wetula D; Biela E; Elas M; Kapka-Skrzypczak L; Lewandowska-Siwkiewicz H; Urbańska K; Kruszewski M Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33653008 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [ Chan C; Fonge H; Lam K; Reilly RM Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737 [TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [ Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317 [TBL] [Abstract][Full Text] [Related]
15. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model. Ghaffari-Nazari H; Alimohammadi M; Alimohammadi R; Rostami E; Bakhshandeh M; Webster TJ; Mahmoodi Chalbatani G; Tavakkol-Afshari J; Amir Jalali S Int Immunopharmacol; 2022 Jul; 108():108737. PubMed ID: 35417831 [TBL] [Abstract][Full Text] [Related]
16. PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases. Sandker GGW; Adema G; Molkenboer-Kuenen J; Wierstra P; Bussink J; Heskamp S; Aarntzen EHJG Front Immunol; 2022; 13():837370. PubMed ID: 35359962 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of c-kit-targeted radioimmunotherapy using 90Y-labeled anti-c-kit antibodies in a mouse model of small cell lung cancer. Yoshida C; Tsuji AB; Sudo H; Sugyo A; Kikuchi T; Koizumi M; Arano Y; Saga T PLoS One; 2013; 8(3):e59248. PubMed ID: 23516616 [TBL] [Abstract][Full Text] [Related]
19. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8 Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Chen P; Cameron R; Wang J; Vallis KA; Reilly RM J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]